Document is current
Any future updates will be listed below
-
Authors
Ploegmakers, Kim J. https://orcid.org/0000-0002-5772-8057
Medlock, Stephanie https://orcid.org/0000-0002-2679-8095
Linn, Annemiek J. https://orcid.org/0000-0003-0912-3712
Lin, Yumin
Seppälä, Lotta J. https://orcid.org/0000-0001-9197-1424
Petrovic, Mirko https://orcid.org/0000-0002-7506-8646
Topinkova, Eva https://orcid.org/0000-0002-6786-4116
Ryg, Jesper https://orcid.org/0000-0002-8641-3062
Mora, Maria Angeles Caballero https://orcid.org/0000-0001-5913-516X
Landi, Francesco
Thaler, Heinrich
Szczerbińska, Katarzyna https://orcid.org/0000-0002-0004-3858
Hartikainen, Sirpa https://orcid.org/0000-0002-4714-455X
Bahat, Gulistan https://orcid.org/0000-0001-5343-9795
Ilhan, Birkan https://orcid.org/0000-0001-6039-5866
Morrissey, Yvonne
Masud, Tahir https://orcid.org/0000-0003-1061-2898
van der Velde, Nathalie https://orcid.org/0000-0002-6477-6209
van Weert, Julia C. M. https://orcid.org/0000-0002-2259-5864
,
-
Funding
Funding for this research was provided by:
amsterdam university fund: clementine brigitta maria dalderup fund (8040)
aging and later life innovation grant, amsterdam public health
- License Information
-
More Information
Article History
Received: 16 June 2021
Accepted: 23 November 2021
First Online: 15 January 2022
Declarations
:
: Sirpa Hartikainen has received lecture fee from Astellas Pharma.
: The Medical Ethical Committee of the Academic Medical Centre of the University of Amsterdam reviewed this study and ruled that no ethical approval was required (W18_285#18.331); this study was approved by the Ethical Committees of the Jagiellonian University in Poland and the Ghent University in Belgium.
: Informed consent was obtained from all individual participants included in the study.
